FDA Webview
X

Free FDA Notices

Comments Sought on Puberty Disorder Research

10/07/2005

Federal Register Notice: The HHS Office for Human Research Protections, Office of Public Health and Science and FDA are soliciting public review and comment on a proposed research protocol entitled “Gonadotropin-releasing Hormone (GnRH) Agonist Test in Disorders of Puberty.” The proposed research would be conducted at the University of Chicago Hospitals General Clinical Research Facility and supported by the National Center for Research Resources of the National Institutes of Health. Written or electronic comments must be received by 11/1 at 4:30 p.m. Electronic copies of the documents for public review can be viewed at the Pediatric Advisory Committee Docket Web site at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/ohrms/dockets/ac/acmenu.htm. (Click on the year 2005 and scroll down to Pediatric Ethics Subcommittee meetings.) To view this notice, click here.

LATEST NEWS